Orbital Therapeutics

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Orbital Therapeutics operates in alternative medicine, biotechnology, life science, therapeutics based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2022.

Within the alternative medicine, biotechnology, life science, therapeutics space, the company focuses on its core offering rather than a broad product line.

The business is associated with Greater Boston Area, East Coast, New England, Northeastern US.

Its current recorded stage is Series_A.

The company reports a headcount in the c_00011_00050 range.

It has disclosed roughly $270M in funding.

Website: orbitaltx.com